FDA Inspection 1234690 — American Red Cross

American Red Cross — FEI 3008821691

The FDA completed an inspection of American Red Cross on March 18, 2024 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 18, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Raleigh, NC (United States)